Literature DB >> 7903025

Control of leukocyte integrin activation.

N Hogg1, J Harvey, C Cabanas, R C Landis.   

Abstract

The integrin receptors on leukocytes are transiently activated by "triggering" molecules that may be other leukocyte membrane structures such as the T-cell receptor complex or small molecules such as PAF, which bind to their own specific receptors. This "inside out" signaling is essential for high affinity integrin/ligand pairing. In the example of LFA-1/ICAM-1, binding is positively supported by Mg2+ but negatively supported by Ca2+. How specific divalent cations affect receptor activation and subsequent ligand binding has still to be fully understood. However, the fact that activation can be mimicked from outside the cell via special anti-LFA-1 monoclonal antibodies such as MEM-83 suggests that activated integrins undergo conformational changes. Further alteration occurs as a result of the interaction of integrin with ligand, and the resulting novel epitopes are named "ligand-induced binding sites." For a brief period of time the integrin/ligand complex is able to transmit signals from "outside in." The transient activation of leukocyte integrins determines that cell-cell adhesion will be short lived and serves the purpose of permitting recycling of effector cells with their targets.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903025     DOI: 10.1164/ajrccm/148.6_Pt_2.S55

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

Review 1.  Demystified...adhesion molecule deficiencies.

Authors:  D Inwald; E G Davies; N Klein
Journal:  Mol Pathol       Date:  2001-02

2.  Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.

Authors:  Brian A Vega; Liam T Schober; Tami Kim; Benjamin A Belinka; Scott C Kachlany
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.

Authors:  Kristina M DiFranco; Anukriti Gupta; Lindsey E Galusha; Jarelys Perez; To-Vy K Nguyen; Camille D Fineza; Scott C Kachlany
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

4.  Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.

Authors:  Anukriti Gupta; Vanessa Espinosa; Lindsey E Galusha; Vahid Rahimian; Katie L Miro; Amariliz Rivera-Medina; Chinnaswamy Kasinathan; Eugenio Capitle; Helen A Aguila; Scott C Kachlany
Journal:  J Leukoc Biol       Date:  2014-10-23       Impact factor: 4.962

5.  LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.

Authors:  Kristina M DiFranco; Nadine Johnson-Farley; Joseph R Bertino; David Elson; Brian A Vega; Benjamin A Belinka; Scott C Kachlany
Journal:  Leuk Res       Date:  2015-03-21       Impact factor: 3.156

6.  Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes.

Authors:  D F Kucik; M L Dustin; J M Miller; E J Brown
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

7.  Cell-cell and cell-matrix adhesion molecules in human heart and lung transplants.

Authors:  G Steinhoff; A Haverich
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

8.  Adhesion between human neutrophils and immobilized endothelial ligand vascular cell adhesion molecule 1: divalent ion effects.

Authors:  Elena B Lomakina; Richard E Waugh
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

9.  Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis.

Authors:  J Highton; B Carlisle; D G Palmer
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.

Authors:  Michael S Forman; Jason B Nishikubo; Rebecca K Han; Amy Le; Nataliya V Balashova; Scott C Kachlany
Journal:  Toxins (Basel)       Date:  2010-12-14       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.